PetIQ, Inc. – NASDAQ:PETQ
PetIQ stock price today
$31
+8.94
+40.53%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 13 hours
PetIQ stock price monthly change
-0.90%
month
PetIQ stock price quarterly change
+18.86%
quarter
PetIQ stock price yearly change
+47.36%
year
PetIQ key metrics
Market Cap | 919.17M |
Enterprise value | 693.94M |
P/E | -6.76 |
EV/Sales | 0.75 |
EV/EBITDA | 43.78 |
Price/Sales | 0.35 |
Price/Book | 1.53 |
PEG ratio | 0.03 |
EPS | 0.25 |
Revenue | 1.11B |
EBITDA | 108.70M |
Income | 7.33M |
Revenue Q/Q | 6.18% |
Revenue Y/Y | 19.61% |
Profit margin | -5.23% |
Oper. margin | 2.94% |
Gross margin | 22.75% |
EBIT margin | 2.94% |
EBITDA margin | 9.71% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePetIQ stock price history
PetIQ stock forecast
PetIQ financial statements
| Jun 2023 | 314.54M | 9.46M | 3.01% |
|---|---|---|---|
| Sep 2023 | 277.01M | 451K | 0.16% |
| Dec 2023 | 219.92M | -17.48M | -7.95% |
| Mar 2024 | 308.44M | 14.90M | 4.83% |
| Sep 2025 | 303.82M | 11.46M | 3.77% |
|---|---|---|---|
| Oct 2025 | 308.93M | 15.90M | 5.15% |
| Dec 2025 | 249.70M | 3.65M | 1.46% |
| Mar 2026 | 339.65M | 16.32M | 4.81% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 883470000 | 647.86M | 73.33% |
|---|---|---|---|
| Sep 2023 | 857089000 | 617.91M | 72.09% |
| Dec 2023 | 868226000 | 645.22M | 74.32% |
| Mar 2024 | 875236000 | 637.38M | 72.82% |
| Jun 2023 | 57.73M | -2.21M | -2.48M |
|---|---|---|---|
| Sep 2023 | 50.32M | -2.07M | -2.25M |
| Dec 2023 | -2.84M | -2.94M | -2.36M |
| Mar 2024 | -85.14M | -822K | -5.07M |
PetIQ alternative data
| Aug 2023 | 1,076 |
|---|---|
| Sep 2023 | 1,076 |
| Oct 2023 | 1,076 |
| Nov 2023 | 1,076 |
| Dec 2023 | 1,076 |
| Jan 2024 | 1,076 |
| Feb 2024 | 1,076 |
| Mar 2024 | 1,121 |
| Apr 2024 | 1,121 |
| May 2024 | 1,121 |
| Jun 2024 | 1,121 |
| Jul 2024 | 1,121 |
PetIQ other data
100.00%
+1.53%
of PETQ is owned by hedge funds
140
+6
30.16M
+1.67M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2021 | 0 | 13500 |
| Feb 2021 | 0 | 4500 |
| Mar 2021 | 0 | 3096118 |
| Apr 2021 | 0 | 9000 |
| May 2021 | 0 | 253635 |
| Jun 2021 | 0 | 70634 |
| Jul 2021 | 0 | 4500 |
| Nov 2021 | 4000 | 0 |
| Dec 2021 | 67083 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | CHRISTENSEN MCCORD director, officer: CHIEF EXECUT.. | Restricted Stock Unit | 2,029 | N/A | N/A | ||
Option | CHRISTENSEN MCCORD director, officer: CHIEF EXECUT.. | Restricted Stock Unit | 5,679 | N/A | N/A | ||
Option | CHRISTENSEN MCCORD director, officer: CHIEF EXECUT.. | Class A Common Stock | 2,029 | N/A | N/A | ||
Option | HERRMAN ROBERT MICHAEL officer: GENERAL .. | Restricted Stock Unit | 676 | N/A | N/A | ||
Option | HERRMAN ROBERT MICHAEL officer: GENERAL .. | Restricted Stock Unit | 1,834 | N/A | N/A | ||
Option | HERRMAN ROBERT MICHAEL officer: GENERAL .. | Class A Common Stock | 676 | N/A | N/A | ||
Option | SHOLTIS SUSAN officer: PRESIDENT | Restricted Stock Unit | 2,944 | N/A | N/A | ||
Option | SHOLTIS SUSAN officer: PRESIDENT | Class A Common Stock | 2,944 | N/A | N/A | ||
Option | SMITH MICHAEL A officer: EVP - PRODUCTS | Restricted Stock Unit | 1,580 | N/A | N/A | ||
Option | SMITH MICHAEL A officer: EVP - PRODUCTS | Class A Common Stock | 1,580 | N/A | N/A |
| Quarter | Transcript |
|---|---|
| Q1 2024 8 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 29 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 8 Aug 2023 | Q2 2023 Earnings Call Transcript |
PetIQ: Cost Savings, Higher EBITDA Suggest A Potential Valuation Re-Rate
PetIQ: Growth Is Back But Getting Pricier Too
PetIQ: Well-Positioned To Grow And Capitalize On The Pet Economy
PetIQ: Steady Growth Play
PetIQ: Looking Smarter, If Margins Return
PetIQ Is A Bet On Steady Trends
Patterson Companies: A Prospect To Brighten Your Smile
Petco Health And Wellness Company: Still Appealing Despite The Market's Reaction
PetIQ: Re-Rating To Upside, Asymmetrical Risk/Reward
-
What's the price of PetIQ stock today?
One share of PetIQ stock can currently be purchased for approximately $31.
-
When is PetIQ's next earnings date?
Unfortunately, PetIQ's (PETQ) next earnings date is currently unknown.
-
Does PetIQ pay dividends?
No, PetIQ does not pay dividends.
-
How much money does PetIQ make?
PetIQ has a market capitalization of 919.17M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 19.58% to 1.1B US dollars.
-
What is PetIQ's stock symbol?
PetIQ, Inc. is traded on the NASDAQ under the ticker symbol "PETQ".
-
What is PetIQ's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of PetIQ?
Shares of PetIQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are PetIQ's key executives?
PetIQ's management team includes the following people:
- Ms. Susan Sholtis Pres(age: 58, pay: $923,590)
- Mr. Michael A. Smith Executive Vice President of Products Division(age: 48, pay: $770,590)
- Mr. Robert Michael Herrman Executive Vice President, Gen. Counsel & Corporation Sec.(age: 56, pay: $562,600)
-
How many employees does PetIQ have?
As Jul 2024, PetIQ employs 1,121 workers.
-
When PetIQ went public?
PetIQ, Inc. is publicly traded company for more then 8 years since IPO on 21 Jul 2017.
-
What is PetIQ's official website?
The official website for PetIQ is petiq.com.
-
Where are PetIQ's headquarters?
PetIQ is headquartered at 230 East Riverside Drive, Eagle, ID.
-
How can i contact PetIQ?
PetIQ's mailing address is 230 East Riverside Drive, Eagle, ID and company can be reached via phone at +20 89398900.
PetIQ company profile:
PetIQ, Inc.
petiq.comExchange:
NASDAQ
Full time employees:
1,121
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at 2,900 community clinics and wellness centers hosted at pet retailers across 42 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.
230 East Riverside Drive
Eagle, ID 83616
Eagle, ID 83616
CIK: 0001668673
ISIN: US71639T1060
CUSIP: 71639T106
